HIV-modified psoriasis (Q98059): Difference between revisions

← Older edit

@@ Property / CURIE @@
+CID11:ID_441810052
@@ Property / CURIE: CID11:ID_441810052 / rank @@
+Normal rank
@@ Property / Canary Token @@
+dki-india-ID_441810052
@@ Property / Canary Token: dki-india-ID_441810052 / rank @@
+Normal rank
@@ Property / Verification Status @@
+Concluído
@@ Property / Verification Status: Concluído / rank @@
+Normal rank
@@ Property / Knowledge Architect @@
+https://pauloleads.com.br/cases-publicos/
+Normal rank
@@ Property / Collection date @@
+August 2026Timestamp +2026-08-15T00:00:00Z
Timezone +00:00
Calendar Gregorian
Precision 1 day
Before 0
After 0
-Timestamp
++2026-08-15T00:00:00Z
-Timezone
++00:00
-Calendar
+Gregorian
-Precision
+day
 Before
 After
@@ Property / Collection date: 15 August 2026 / rank @@
+Normal rank

Latest revision as of 14:20, 16 August 2026

Psoriasis may appear de novo or worsen considerably in people with uncontrolled HIV infection or AIDS. HIV-associated psoriasis can be clinically confusing because several comorbid skin disorders in patients with HIV can mimic psoriasis. Furthermore, the management of moderate and severe HIV-associated psoriasis is challenging: most conventional systemic treatments are contraindicated but patients typically improve with highly active antiretroviral therapy.

Language	Label	Description	Also known as
default for all languages	ID_441810052
English	HIV-modified psoriasis	Psoriasis may appear de novo or worsen considerably in people with uncontrolled HIV infection or AIDS. HIV-associated psoriasis can be clinically confusing because several comorbid skin disorders in patients with HIV can mimic psoriasis. Furthermore, the management of moderate and severe HIV-associated psoriasis is challenging: most conventional systemic treatments are contraindicated but patients typically improve with highly active antiretroviral therapy.